Results 121 to 130 of about 820 (178)

P2.09-24 MERS67 is a Novel anti-NaPi2b Antibody and Demonstrates Differential Expression Patterns in Lung Cancer Histologic Subtypes [PDF]

Journal of Thoracic Oncology, 2018
H. Yu, R. Mosher, K. Ellison, P. Shaw, R. Dziadziuszko, E. Hailman, C. Rivard, F. Hirsch   +7 more
openaire   +1 more source

Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective. [PDF]

Med Sci Monit
Abramiuk M, Skrabalak I, Satora M, Ostrowska-Leśko M, Czech MJ, Majchrzak J, Bobiński M.   +6 more
europepmc   +1 more source

Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems. [PDF]

Int J Nanomedicine
Lin Q, Li J, Abudousalamu Z, Sun Y, Xue M, Yao L, Chen M.   +6 more
europepmc   +1 more source

Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia

, 2022
Michihiro Maemoto, Yuuki Hirata, Shintaro Hosoe, Jun Ouchi, Kazuya Narushima, Emi Akizawa, Yoshiro Tsuji, Hidenori Takada, Arata Yanagisawa, Satoshi Shuto   +9 more
openalex   +1 more source

Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses. [PDF]

Nat Commun
Malli Cetinbas N, Monnell T, Soomer-James J, Shaw P, Lancaster K, Catcott KC, Dolan M, Mosher R, Routhier C, Chin CN, Toader D, Duvall J, Bukhalid R, Lowinger TB, Damelin M.   +14 more
europepmc   +1 more source

Chemotherapy-free combination strategies in recurrent platinum-resistant ovarian cancer: promise, evidence and perspectives. [PDF]

Transl Cancer Res
Corbaux P, Freyer G.
europepmc   +1 more source

Creation of cellular models for the analysis of sodium-dependent phosphate transporter NaPi2b, a potential marker for ovarian cancer [PDF]

, 2009
Vitalina Gryshkova, Dmytro Lituyev, Valeriy Filonenko, Ramziya Kiyamova   +3 more
openalex   +1 more source

Advances in ovarian cancer: biological insights, therapeutic innovations, and future perspectives. [PDF]

J Ovarian Res
Ma X, Qu L, Wu Q, Yu Q, Lin Z, Yang Y, Zhou X.   +6 more
europepmc   +1 more source

Supplementary Figure 9 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile

Annette M. Vogl, Saskia Schmitt, Isabelle Mai, Paul Machui, Sarah Herterich, Natascia Leonardi, Philipp Cyprys, Danila Hauswald, Philipp Ochtrop, Izabela Kozlowska, Annabel Kitowski, Marcus Gerlach, Florian Waldmann, Olivier Marcq, Pamela A. Trail, Dominik Schumacher, Günter R. Fingerle-Rowson, Björn Hock, Marc‐André Kasper, Jonas Helma   +19 more
openalex   +1 more source

Monotherapy and combination therapy using antibody‑drug conjugates for platinum‑resistant ovarian cancer. [PDF]

Oncol Rep
Shen K, Yuan S, Su N, Tang F, Rehim S, Wang H, Guo H, Zhang Y, Wu Y, Wang H.   +9 more
europepmc   +1 more source